The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.

ShadiSadat SeyyedebrahimiHadi KhodabandehlooEnsieh Nasli EsfahaniReza Meshkani

Published in: Acta diabetologica (2018)

Our study demonstrated that 8 weeks of supplementation with 800 mg/day resveratrol has an antioxidant effect in the blood and PBMCs of patients with T2D. Clinical Trial Registry number and website IRCT registration number: IRCT2015072523336N1 and http://en.search.irct.ir/view/24752 .

Keyphrases

double blind
clinical trial
placebo controlled
oxidative stress
phase ii
phase iii
study protocol
phase ii study
randomized controlled trial
squamous cell carcinoma
diabetic rats
gestational age
induced apoptosis
preterm birth